(Q55473284)

12 July 2018

title

Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12. (English)

1 reference

12 July 2018

author name string

Ian F Parney

1

1 reference

12 July 2018

Maxine A Farr-Jones

2

1 reference

12 July 2018

Kevin Kane

3

1 reference

12 July 2018

Lung-Ji Chang

4

1 reference

12 July 2018

Kenneth C Petruk

5

1 reference

12 July 2018

publication date

1 August 2002

1 reference

12 July 2018

Canadian Journal of Neurological Sciences

published in

1 reference

12 July 2018

volume

29

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

267-275

1 reference

12 July 2018

A simple and reproducible experimental in vivo glioma model.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

In vitro photoradiation therapy of the rat 9L gliosarcoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Angiogenesis in malignant gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Tumor antigens in astrocytic gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Use of retroviral vectors for gene transfer and expression

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100002055

1 reference

7 January 2021

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

The B7 and CD28 receptor families

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Modulation of T-cell function by gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumo

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Angiogenesis in brain tumors; pathobiological and clinical aspects

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Human glioma immunobiology in vitro: implications for immunogene therapy.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong costimulation activity

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Surface proteins involved in T cell costimulation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

The future of therapy for glioblastoma

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

Improved technique for establishing short term human brain tumor cultures.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100002055

7 January 2021

10.1017/S0317167100002055

Identifiers

DOI

0 references

PubMed ID

12195617

1 reference

12 July 2018